Clinical Trial Update: Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 long-term study of CS-3150 as monotherapy or in combination for essential hypertension in Japanese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• CS-3150 (CS-3150)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED